Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects
Autoren
Ring A, Rathgen K, Stangier J, Reilly P, Clemens A, Friedman J
Journal
Clin Drug Investig
Veröffentlichungsdatum
2013
Impact Factor
1.915
Abstract
Weitere IDs
Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens